Department of Medicine
Faculty Profiles by Division

Division of Infectious Diseases

Faculty Profiles

[Return To Index page]
photo Yijia Li, MD

Infectious Diseases

Clinical Assistant Professor of Medicine

Email: liy33@upmc.edu

Phone: 412-647-7228

Contact
Office: 3601 Fifth Ave
7th Floor, Falk Medical Building
Pittsburgh, PA 15213
 
Phone: 412-647-7228
Fax: 412-647-7951
E-mail: liy33@upmc.edu
Education and Training
Education
MD, Peking Union Medical College, 2015
Pre-Medical Education, Tsinghua University, 2010
Training
Infectious Diseases Fellowship, Massachusetts General Hospital/Brigham and Women's Hospital Combined Program, 2021
Internal Medicine Residency, UPMC Presbyterian, 2019
Research Interest
HIV/AIDS
-Viro-Immunological factors associated with HIV remission
-HIV drug resistance mutations
-Non-AIDS complications

Viral Hepatitis
-HIV/HBV co-infection

SARS-CoV-2
-Viro-Immunological factors associated with COVID-19 severity, SARS-CoV-2 RNAemia/Viremia, symptomatology
Clinical Interest
HIV/AIDS, Viral Hepatitis, Sexual Health
Educational Interest
HIV/AIDS, Viral Hepatitis
Publications
For my complete bibliography, Click Here.
Selected Publications:
Li Y*, Choudhary MC*, Regan J*, Boucau J, Nathan A, Speidel T, Liew MY, Edelstein GE, Kawano Y, Uddin R, Deo R, Marino C, Getz MA, Reynolds Z, Barry M, Gilbert RF, Tien D, Sagar S, Vyas TD, Flynn JP, Hammond SP, Novack LA, Choi B, Cernadas M, Wallace ZS, Sparks JA, Vyas JM, Seaman MS, Gaiha GD, Siedner MJ, Barczak AK, Lemieux JE, Li JZ. *, Equal Contribution. SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency. Science Translational Medicine. 2024; 16(731): eadk1599.
Mohammadi A, Etemad B, Zhang X, Li Y, Bedwell GJ, Sharaf R, Kittilson A, Melberg M, Wong C, Fajnzylber J, Worrall DP, Rosenthal A, Jordan H, Jilg N, Kaseke C, Giguel F, Lian X, Deo R, Gillespie E, Chishti R, Abrha S, Adams T, Siagian A, Anderson PL, Deeks SG, Lederman MM, Yawetz S, Kuritzkes DR, Lichterfeld MD, Tsibris A, Carrington M, Brumme ZL, Castillo-Mancilla JR, Engelman AN, Gaiha GD, Li JZ. Viral and host mediators of non-suppressible HIV-1 viremia. Nature Medicine. 2023; https://doi.org/10.1038/s41591-023-02611-1.
Esmaeilzadeh E, Etemad B, Lavine CL, Garneau L, Li Y, Regan J, Wong C, Sharaf R, Connick E, Volberding P, Sagar M, Seaman MS, Li JZ. Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption. Science Translational Medicine. 2023; 15(695): eabq4490.
Etemad B*, Sun X*, Li Y*, Melberg M, Moisi D, Gottlieb R, Ahmed H, Aga E, Bosch RJ, Acosta EP, Yuki Y, Martin MP, Carrington M, Gandhi RT, Jacobson JM, Volberding P, Connick E, Mitsuyasu R, Frank I, Saag M, Eron JJ, Skiest D, Margolis DM, Havlir D, Schooley RT, Lederman MM, Yu XG, Li JZ. *, Equal Contribution. HIV post-treatment controllers have distinct immunological and virological features. Proceedings of the National Academy of Sciences of the United States of America. 2023; 120(11): e2218960120.
Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS; ACTIV-2/A5401 Study Team, Hughes MD, Smith DM. Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nature Communications. 2022; 13(1): 4931.
Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs R, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19. Clinical Infectious Diseases. 2023.
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Lipiner T, Kittilson A, Melberg M, Li Y, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Goldberg MB, Vyas JM, Li JZ, Lemieux JE, Siedner MJ, Barczak AK. Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection. New England Journal of Medicine. 2022; 387(3): 275-277.
Li Y. Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave. Journal of the American Medical Association. 2022; 327(21): 2147-2148.
Li Y, Schneider AM, Mehta A, Sade-Feldman M, Kays KR, Gentili M, Charland NC, Gonye AL, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Parry BA, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Regan J, Flynn JP, Villani AC, Hacohen N, Goldberg MB, Filbin MR, Li JZ. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. Journal of Clinical Investigation. 2021; 131(13): e148635.
Li Y, Etemad B, Dele-Oni R, Sharaf R, Gao C, Lichterfeld M, Li JZ. Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation. AIDS. 2021; 35(7): 1015-1020.
Notable Achievements
Maxwell Finland Award for Excellence in Research- Massachusetts Infectious Diseases Society, 2022
Edward H. Kass Award for Clinical Excellence in Infectious Diseases- Massachusetts Infectious Diseases Society, 2021
Editorial Advisory Board of Open Forum Infectious Diseases, 2021-Present
Young Investigator Scholarship- CROI, 2021/2019/2016
International Scholarship Award- IAS, 2015